BVF Partners, Director: Olema Pharmaceuticals OLMA Buy · Filed 23/09/14

Trade details

Type: Insider buy
Amount: $7,628,735.52
Shares · price: 775,278 sh · $9.84 a share
Held after: 4,688,954 sh
Stock: Olema Pharmaceuticals OLMA
Person: BVF PartnersDirector
Trade date: 23/09/12
Filed: 23/09/14
Days to filing: 2 days

11 insiders bought this week

Insiders buying this week: 11 insiders
Holding change: +19.8%

Olema Pharmaceuticals trades, last 26 weeks

What else happened in Olema Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/08/13~23/10/12

BVF Partners's recent trades

BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$89.2M
837,914 sh
$89.2M
Filed 06/26
Traded 06/26
BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$66.8M
627,597 sh
$66.8M
Filed 06/26
Traded 06/26
BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$12.1M
113,289 sh
$12.1M
Filed 06/26
Traded 06/26
BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$5.5M
51,858 sh
$5.5M
Filed 06/26
Traded 06/26
BVF PartnersSEE REMARKS and Footnotes
Planned saleKymera Therapeutics
Planned sale
Kymera Therapeutics
KYMR
$189.9M
1,630,658 sh
$189.9M
Filed 06/26
Traded 06/26

BVF Partners, Director — bought $7.6M of Olema Pharmaceuticals OLMA · 775,278 sh @ $9.84 | Whalegun